This trial is testing if the drug buspirone is safe and effective for treating anxiety in kids with autism spectrum disorders. The results will be used to plan a larger study with more participants.
2 Primary · 0 Secondary · Reporting Duration: Baseline to 8 weeks
9 Total Participants · 1 Treatment Group
Primary Treatment: Buspirone · No Placebo Group · N/A
Age < 18 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: